Both in Pharmaceuticals
Corcept Therapeutics vs Arrowhead Research
Over the past year CORT returned +8.5% and ARWR returned +50.4%; their daily moves had a correlation of 0.15.
CORT +8.5% ARWR +50.4%Growth of $1, one year, split-adjusted
| Metric | CORT | ARWR |
|---|---|---|
| Price | $80.46 | $59.57 |
| Market cap | $8.70B | $8.41B |
| Today | −0.81% | −0.55% |
| 1 month | −30.8% | −7.2% |
| 6 months | +55.9% | −22.0% |
| Year to date | +131.2% | −10.3% |
| 1 year | +11.3% | +40.8% |
| Revenue growth (YoY) | +31.7% | +171.0% |
| Gross margin | 98.4% | 100.0% |
| Net margin | 16.8% | −258.2% |
| P/E (TTM) | 159.6× | — |
| Price / sales | 10.5× | 12.6× |
| Net cash | $308.2M | $737.9M |
| Dividend yield | — | — |
| Volatility (60d) | 59.6% | 45.2% |
| Short % of float | 9.0% | 8.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).